Nestmedic (WAR:NST) Cyclically Adjusted FCF per Share: zł-0.81 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:NST Nestmedic SA WAR:NST
37 GF Score
Price zł0.72
GF Value zł0.41
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Nestmedic Cyclically Adjusted FCF per Share?

Nestmedic WAR:NST +3.75% 37 Cyclically Adjusted FCF per Share is zł-0.81 as of Mar. 2026. GuruFocus rates WAR:NST with a GF Score™ of 37/100 and a GF Value™ of zł0.41 (Significantly Overvalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Nestmedic's adjusted free cash flow per share for the three months ended in Mar. 2026 was zł-0.041. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is zł-0.81 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-16), Nestmedic's current stock price is zł0.72. Nestmedic's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was zł-0.81. Nestmedic's Cyclically Adjusted Price-to-FCF of today is .


Nestmedic  (WAR:NST) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Nestmedic Cyclically Adjusted FCF per Share Related Terms


Nestmedic Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Nestmedic's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nestmedic Cyclically Adjusted FCF per Share Chart

Nestmedic Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Nestmedic Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.81

WAR:NST vs ABT, SYK, MDT: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Nestmedic's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nestmedic Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nestmedic's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Nestmedic's Cyclically Adjusted Price-to-FCF falls into.


WAR:NST
37GF Score
Nestmedic SA WAR:NST
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nestmedic Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Nestmedic's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.041/163.0700*163.0700
=-0.041

Current CPI (Mar. 2026) = 163.0700.

Nestmedic Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201512 0.000 99.471 0.000
201609 -0.349 99.064 -0.574
201612 -0.087 100.366 -0.141
201703 0.699 101.018 1.128
201706 -1.088 101.180 -1.754
201709 -0.279 101.343 -0.449
201712 -0.283 102.564 -0.450
201803 -0.277 102.564 -0.440
201806 -0.175 103.378 -0.276
201809 -0.054 103.378 -0.085
201812 0.003 103.785 0.005
201903 -0.091 104.274 -0.142
201906 -0.137 105.983 -0.211
201909 -0.237 105.983 -0.365
201912 -0.227 107.123 -0.346
202003 -0.128 109.076 -0.191
202006 -0.112 109.402 -0.167
202009 -0.179 109.320 -0.267
202012 -0.160 109.565 -0.238
202103 -0.047 112.658 -0.068
202106 -0.216 113.960 -0.309
202109 -0.284 115.588 -0.401
202112 -0.291 119.088 -0.398
202203 -0.342 125.031 -0.446
202206 -0.128 131.705 -0.158
202209 -0.062 135.531 -0.075
202212 -0.073 139.113 -0.086
202303 -0.105 145.950 -0.117
202306 -0.097 147.009 -0.108
202309 -0.038 146.113 -0.042
202312 -0.059 147.741 -0.065
202403 -0.055 149.044 -0.060
202406 -0.055 150.997 -0.059
202409 -0.034 153.439 -0.036
202412 -0.268 154.660 -0.283
202503 -0.038 157.021 -0.039
202506 -0.037 157.509 -0.038
202509 -0.066 158.000 -0.068
202512 -0.062 158.320 -0.064
202603 -0.041 163.070 -0.041

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of zł-0.81 mean?
Nestmedic (WAR:NST) has a Cyclically Adjusted FCF per Share of zł-0.81 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Nestmedic and its competitors.
Is Nestmedic's Cyclically Adjusted FCF per Share too high?
Nestmedic's current Cyclically Adjusted FCF per Share is zł-0.81. Overall, Nestmedic has a GF Score™ of 37/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nestmedic's Cyclically Adjusted FCF per Share compare to ABT and SYK?
Nestmedic's Cyclically Adjusted FCF per Share of zł-0.81 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Nestmedic and its competitors. Nestmedic's current Cyclically Adjusted FCF per Share is zł-0.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nestmedic stock overvalued right now?
Based on GuruFocus' analysis, Nestmedic (WAR:NST) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.41, compared to a current price of zł0.72 — trading 75.6% above its estimated fair value. The current Cyclically Adjusted FCF per Share is zł-0.81. Nestmedic's overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Nestmedic (WAR:NST), the current Cyclically Adjusted FCF per Share is zł-0.81 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nestmedic (WAR:NST) Overvalued in 2026?

Based on GuruFocus' analysis, Nestmedic stock appears to be overvalued. The current stock price of zł0.72 is trading 75.6% above its estimated GF Value™ of zł0.41. GuruFocus considers Nestmedic to be Significantly Overvalued.

Key valuation signals for WAR:NST:

  • Cyclically Adjusted FCF per Share: zł-0.81
  • GF Value™: zł0.41 vs. price of zł0.72 (75.6% above fair value)
  • GF Score™: 37/100 with 5 warning signs

No single metric tells the full story. See the WAR:NST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nestmedic Business Description

Address ul. Pasymska 20, Warszawa, POL, 01-993
Nestmedic SA is a manufacturer of mobile telemedicine solution Pregnabit for remote fetal well-being - cardiotocographic (KTG). Pregnabit consists of a medical device (teleKTG) allowing to reliably and safely retrieve data using certified medical probes.
37GF Score

Get the complete analysis for WAR:NST

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.72
Price
zł0.41
GF Value